Search

Search Results

12 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• Research PaperVolume 12, Issue 23pp 24255-24269

  Exploring the mechanism of resistance to sorafenib in two hepatocellular carcinoma cell lines

  Relevance score: 0.00

  Zhi Zhang, Cheng-Zu He, Ya-Qin Qin, Jian-Jun Liao, Shang-Tao Huang, Steven Mo, Hong-Mian Li, Jian-Yan Lin

  Keywords: sorafenib, hepatocellular carcinoma, drug resistance, miRNA, transcription factors

  Published in Aging on November 21, 2020

  Show abstract
• Research PaperVolume 15, Issue 13pp 6503-6525

  Galectin-1-mediated MET/AXL signaling enhances sorafenib resistance in hepatocellular carcinoma by escaping ferroptosis

  Relevance score: 0.00

  Tung-Wei Hsu, Yen-Hao Su, Hsin-An Chen, Po-Hsiang Liao, Shih Chiang Shen, Kuei-Yen Tsai, Tzu-Hsuan Wang, Alvin Chen, Chih-Yang Huang, Marthandam Asokan Shibu, Wan-Yu Wang, Shing-Chuan Shen

  Keywords: Galectin-1, sorafenib resistance, ferroptosis, hepatocellular carcinoma

  Published in Aging on July 11, 2023

  Show abstract
• Research PaperVolume 13, Issue 3pp 3969-3993

  Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma

  Relevance score: 0.00

  Wei Yuan, Ran Tao, Da Huang, Weiming Yan, Guanxin Shen, Qin Ning

  Keywords: transcriptomics, sorafenib resistance, hepatocellular carcinoma, immune filtrates, bioinformatics

  Published in Aging on January 20, 2021

  Show abstract
• Research PaperVolume 12, Issue 18pp 18192-18208

  MicroRNA-216a-3p promotes sorafenib sensitivity in hepatocellular carcinoma by downregulating MAPK14 expression

  Relevance score: 0.00

  Zhong Wan, Tingyu Liu, Liang Wang, Rong Wang, Hai Zhang

  Keywords: hepatocellular carcinoma, MAPK14, sorafenib resistance, miR-216a-3p

  Published in Aging on September 21, 2020

  Show abstract
• Research PaperVolume 12, Issue 18pp 18127-18136

  GHR knockdown enhances the sensitivity of HCC cells to sorafenib

  Relevance score: 0.00

  Shuang Gao, Qianwen Ni, Xiuli Wu, Tieliu Cao

  Keywords: hepatocellular carcinoma, sorafenib, GHR, resistance, PI3K/AKT/ERK1/2 signaling pathway

  Published in Aging on September 24, 2020

  Show abstract
• Research PaperVolume 11, Issue 24pp 12452-12475

  Mitochondrial metabolic study guided by proteomics analysis in hepatocellular carcinoma cells surviving long-term incubation with the highest dose of sorafenib

  Relevance score: 0.00

  Jing Bai, Ziqi Liu, Jiang Liu, Saihang Zhang, Yuan Tian, Yueshan Zhang, Leiming Ren, Dezhi Kong

  Keywords: hepatocellular carcinoma, insensitivity, mitochondria, complex I, sorafenib

  Published in Aging on December 26, 2019

  Show abstract
• Research PaperVolume 13, Issue 2pp 1872-1882

  Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer

  Relevance score: 0.00

  Zhili Wen, Yuliang Feng, Youwen Hu, Lingyan Lian, Hongyan Huang, Li Guo, Shanwen Chen, Qian Yang, Moran Zhang, Lijun Wan, Kedong Xu, Degejirifu, Xiaohua Yan

  Keywords: multiwalled carbon nanotubes, sorafenib, epidermal growth factor receptor, liver cancer

  Published in Aging on January 13, 2021

  Show abstract
• Research PaperVolume 12, Issue 22pp 22975-23003

  Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma

  Relevance score: 0.00

  Qiankun Zhu, Haiyang Ren, Xiaodong Li, Bo Qian, Shengjie Fan, Fengli Hu, Lishan Xu, Bo Zhai

  Keywords: hepatocellular carcinoma, sorafenib, human kinesin family member 14, transcription factor E26 transformation specific sequence 1, phosphatidylinositol 3-kinase/AKT signalling pathway

  Published in Aging on November 16, 2020

  Show abstract
• Research PaperVolume 11, Issue 15pp 5769-5785

  The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells

  Relevance score: 0.00

  Jialiang Wang, Huan Wei, Yanlin Huang, Dongmei Chen, Guofen Zeng, Yifan Lian, Yuehua Huang

  Keywords: lonafarnib, sorafenib, autophagy, DNA synthesis, hepatocellular carcinoma

  Published in Aging on August 13, 2019

  Show abstract
• RetractionVolume 16, Issue 13pp 11120-11121

  Retraction for: Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer

  Relevance score: 0.00

  Zhili Wen, Yuliang Feng, Youwen Hu, Lingyan Lian, Hongyan Huang, Li Guo, Shanwen Chen, Qian Yang, Moran Zhang, Lijun Wan, Kedong Xu, Degejirifu, Xiaohua Yan

  Keywords: multiwalled carbon nanotubes, sorafenib, epidermal growth factor receptor, liver cancer

• Research PaperVolume 15, Issue 21pp 12251-12263

  Polyphyllin I attenuates the invasion and metastasis via downregulating GRP78 in drug-resistant hepatocellular carcinoma cells

  Relevance score: 0.00

  Haiyan Du, Haochen Wu, Qinyang Kang, Mianmian Liao, Meirong Qin, Ning Chen, Houshuang Huang, Danping Huang, Ping Wang, Guangdong Tong

  Keywords: Polyphyllin I, invasion and metastasis, sorafenib-resistant, GRP78, hepatocellular carcinoma

  Published in Aging on November 6, 2023

  Show abstract
• Research PaperVolume 16, Issue 1pp 348-366

  SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis

  Relevance score: 0.00

  Xiaoyan Wang, Hao Zhang, Zehao Guo, Junyuan Wang, Chuntao Lu, Junhua Wang, Rongzhong Jin, Zhijing Mo

  Keywords: SNRPB, HCC, oxidative stress, cell cycle, sorafenib

  Published in Aging on January 5, 2024

  Show abstract